Neutrogena and Malin Akerman to Educate About Skin Cancer Detection

The Neutrogena(R) Partnership for Skin Health, a public service initiative that partners with organizations and individuals to educate, promote advancements and explore solutions for skin health, has tapped actress Malin Akerman to educate consumers in a viral video about self-examination for skin cancer detection.� As the #1 dermatologist
recommended skincare brand and the leader in sun protection technology,
Neutrogena(R) is committed to educating and empowering individuals about the
importance of self-examinations to detect skin cancer in its earliest and most
treatable stage.
The viral video, starring Akerman, shows a couple performing skin self
checks to demonstrate how easy it is to engage with a loved one for early
detection of skin cancer.� The goal of the video is to empower consumers to
take control of their health and encourage both men and women to check
themselves for skin cancer.
“The viral video shows how skin examinations can be fun, while
communicating the seriousness of the skin cancer message,” said Jim Colleran,
President, Neutrogena(R) Corporation.� “This video is meant to create buzz,
spark conversation and serve as a ‘wake-up call’ to consumers about the
importance of self-examination in detecting skin cancer.”
“This video and message is something I have a passion for because I
understand the importance of checking your skin for suspicious moles,” says
Malin Akerman.� “I recently had a suspicious mole removed from my face; I
noticed it was changing shape and asked my dermatologist to examine it.� I was
one of the luckier ones because it wasn’t cancerous.”
Skin cancer is the most common form of cancer in the US; one in five
Americans will develop skin cancer during his or her lifetime.� The
Neutrogena(R) Partnership for Skin Health set out to create a viral video that
would reach a wide-scale audience, including both men and women.� Having a
loved one check your moles (especially on areas of your body that are harder
for you to see and reach) aids in the early detection of skin cancer.
About Malin Akerman:� Akerman relocated to the U.S. from Canada in 2001 to
pursue her love of acting.� Since 2001, she has quickly been building her film
career.� This spring, Akerman appeared in the romantic comedy 27 DRESSES.� In
the fall of 2007, Akerman landed the lead role in THE HEARTBREAK KID directed
by the Farrelly Brothers, co-starring Ben Stiller; and in the Screen Gems
comedy THE BROTHERS SOLOMON directed by Bob Odenkirk.� On the small screen,
Akerman impressed critics and audiences alike with her portrayal of “Juna
Millken” in the HBO series THE COMEBACK.� She also had a memorable recurring
role in the third season of ENTOURAGE.� Akerman has just completed work as one
of the title characters in WATCHMEN for 300 Director, Zack Snyder.� The film
co-stars Billy Cruddup, Carla Gugino and Patrick Wilson and is due out in
March 2009.
About the Neutrogena(R) Partnership for Skin Health (NPSH):� An initiative
to partner with organizations and individuals to educate, promote advancements
and explore solutions for skin health, the NPSH aims to focus resources on
programs that will elevate skin health awareness, resulting in greater change.
About Neutrogena(R):� A worldwide leader in premium,
dermatologist-recommended skin, hair and cosmetics products, Neutrogena(R) has
been providing consumers with health and beauty improvements for more than 40
years.� The Company manufactures and markets a line of premium-priced skin and
hair care products that are distributed in more than 70 countries.
Headquartered in Los Angeles, Neutrogena(R) is a subsidiary of Johnson &
Johnson, the world’s most comprehensive and broadly based health care products
company.
Related to Neutrogena and Malin Akerman to Educate About Skin Cancer Detection:
If you enjoyed this post, please consider leaving a comment, subscribe to the feed and get future articles delivered to your feed reader or follow us on Twitter.
[…] Neutrogena and Malin Akerman to Educate About <b>Skin</b> Cancer Detection […]